Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 5/20 | 0.47 |
| ▸ | MAOA | P21397 | 2/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.46 |
| ▸ | THRA | P10827 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | AS3MT | Q9HBK9 | 1/20 | 0.40 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11394076 | 0.86 | MAOB (0.39) | MAOBMAOACYP3A4 | |
| SCHEMBL27693392 | 0.82 | MAOB (0.47) | MAOBMAOA | |
| SCHEMBL5546017 | 0.81 | MAOB (0.53) | MAOBMAOACYP19A1THRATHRB | |
| SCHEMBL5165545 | 0.81 | MAOB (0.47) | MAOBMAOACYP19A1THRATHRB | |
| SCHEMBL12548720 | 0.79 | MGLL (0.32) | — | |
| Ethoxycarbonyl Group SCHEMBL28280206 | 0.79 | CYP3A4 (0.43) | MAOBMAOACYP19A1CYP3A4CASP1 | |
| SCHEMBL7359415 | 0.78 | ENPP2 (0.50) | CYP3A4CA2CA9CA12ALDH1A1 | |
| SCHEMBL366865 | 0.77 | MAOB (0.56) | MAOBMAOACYP19A1THRATHRB | |
| SCHEMBL95134 | 0.77 | IDO1 (0.58) | MAOBMAOA | |
| SCHEMBL15723548 | 0.77 | MRGPRX4 (0.45) | MAOBMAOAMRGPRX4CYP11B1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118339165-A | Antibody-drug conjugates and methods of use thereof | R.P.谢勒技术有限责任公司 | 2024-07-12 | — | — | CN | claimed |
| US-20240197907-A1 | Dual-Cleavage Ester Linkers for Antibody-Drug Conjugates | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2024-06-20 | — | — | US | claimed |
| US-20240166693-A1 | METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPY 1 | Design Therapeutics, Inc. | 2024-05-23 | — | — | US | claimed |
| US-20240148883-A1 | Branched Linkers for Antibody-Drug Conjugates and Methods of Use Thereof | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2024-05-09 | — | — | US | claimed |
| US-20240124491-A1 | METHODS AND COMPOUNDS FOR TREATING FRIEDREICH'S ATAXIA | Design Therapeutics, Inc. | 2024-04-18 | — | — | US | claimed |
| WO-2024054821-A2 | TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND USES THEREOF | EXELIXIS, INC. (US) | 2024-03-14 | — | — | WO | claimed |
| CN-117279662-A | Branched linkers for antibody-drug conjugates and methods of use thereof | R.P.谢勒技术有限责任公司 | 2023-12-22 | — | — | CN | claimed |
| EP-4274583-A2 | METHODS AND COMPOUNDS FOR TREATING FRIEDREICH'S ATAXIA | Design Therapeutics, Inc. (US) | 2023-11-15 | — | — | EP | claimed |
| EP-4259133-A1 | METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPHY 1 | Design Therapeutics, Inc. (US) | 2023-10-18 | — | — | EP | claimed |
| CN-116847844-A | Camptothecine antibody-drug conjugates and methods of use thereof | R.P.谢勒技术有限责任公司 | 2023-10-03 | — | — | CN | claimed |
| US-20190192680-A1 | Hydrazinyl-Substituted Heteroaryl Compounds and Methods for Producing a Conjugate | REDWOOD BIOSCIENCE, INC. | 2019-06-27 | — | — | US | claimed |
| WO-2019113248-A1 | ANTI-UPAR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-06-13 | — | — | WO | claimed |
| US-10195283-B2 | Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugate | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2019-02-05 | — | — | US | claimed |
| US-20180215783-A1 | BIOORTHOGONAL REACTION OF AN AMINE N-OXIDE AND A BORON AGENT | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2018-08-02 | — | — | US | claimed |
| US-20170266302-A1 | Hydrazinyl-Substituted Heteroaryl Compounds and Methods for Producing a Conjugate | R.P. SCHERER TECHNOLOGIES, LLC | 2017-09-21 | — | — | US | claimed |
| US-20170049907-A1 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | CATALENT PHARMA SOLUTIONS, LLC | 2017-02-23 | — | — | US | claimed |
| US-9493413-B2 | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate | REDWOOD BIOSCIENCE, INC. (US) | 2016-11-15 | — | — | US | claimed |
| EP-3074010-A1 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | Redwood Bioscience, Inc. (US) | 2016-10-05 | — | — | EP | claimed |
| US-20150157736-A1 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | R.P. SCHERER TECHNOLOGIES, LLC | 2015-06-11 | — | — | US | claimed |
| WO-2015081282-A1 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | REDWOOD BIOSCIENCE, INC. (US) | 2015-06-04 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240124491-A1 | METHODS AND COMPOUNDS FOR TREATING FRIEDREICH'S ATAXIA | ATXN2, ATXN2L, CDR2 | MAOB 1034/4885MAOA 1289/4885CYP19A1 4797/4885 |
| US-20150157736-A1 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | DNPEP, QPCT, PDS5A | MAOB 1555/4885MAOA 1392/4885CYP19A1 2570/4885 |
| US-20240197907-A1 | Dual-Cleavage Ester Linkers for Antibody-Drug Conjugates | ADAM8, BCR, JMJD7 | MAOB 1662/4885MAOA 1553/4885CYP19A1 1141/4885 |
| US-20170049907-A1 | HYDRAZINYL-PYRROLO COMPOUNDS AND METHODS FOR PRODUCING A CONJUGATE | DNPEP, QPCT, PDS5A | MAOB 1555/4885MAOA 1392/4885CYP19A1 2570/4885 |
| US-20240166693-A1 | METHODS AND COMPOUNDS FOR MODULATING MYOTONIC DYSTROPY 1 | MTPN, DMPK, MBNL1 | MAOB 2507/4885MAOA 3033/4885CYP19A1 4649/4885 |
| US-20180215783-A1 | BIOORTHOGONAL REACTION OF AN AMINE N-OXIDE AND A BORON AGENT | BBOX1, BLVRB, BTD | MAOB 11/4885MAOA 48/4885CYP19A1 627/4885 |
| US-10195283-B2 | Hydrazinyl-substituted heteroaryl compounds and methods for producing a conjugate | HNMT, TIAL1, HACL2 | MAOB 625/4885MAOA 448/4885CYP19A1 1001/4885 |
| US-20190192680-A1 | Hydrazinyl-Substituted Heteroaryl Compounds and Methods for Producing a Conjugate | HNMT, TIAL1, HACL2 | MAOB 625/4885MAOA 448/4885CYP19A1 1001/4885 |
| US-20170266302-A1 | Hydrazinyl-Substituted Heteroaryl Compounds and Methods for Producing a Conjugate | HNMT, TIAL1, HACL2 | MAOB 625/4885MAOA 448/4885CYP19A1 1001/4885 |
| US-20240148883-A1 | Branched Linkers for Antibody-Drug Conjugates and Methods of Use Thereof | CD22, CLTB, BCR | MAOB 1061/4885MAOA 1574/4885CYP19A1 4371/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.